Company registration number 04893302 (England and Wales)
C D MEDICAL (BOLTON) LIMITED
ANNUAL REPORT
AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2023
C D MEDICAL (BOLTON) LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2
C D MEDICAL (BOLTON) LIMITED
BALANCE SHEET
AS AT
31 JANUARY 2023
31 January 2023
- 1 -
2023
2022
Notes
£
£
£
£
Current assets
Debtors
2
100
100
Net current assets
100
100
Capital and reserves
-
-
Called up share capital
100
100

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 January 2023 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 11 October 2023 and are signed on its behalf by:
Mr  B Miller
Director
Company Registration No. 04893302
C D MEDICAL (BOLTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2023
- 2 -
1
Accounting policies
Company information

C D Medical (Bolton) Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit F, Lostock Office Park, Lynstock Way, Lostock, Bolton.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Profit and loss account

The company has not traded during the year or the preceding financial period. During this time, the company received no income and incurred no expenditure and therefore no Profit and loss account is presented in these financial statements.

1.3
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Debtors
2023
2022
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
100
100
3
Related party transactions

The company has taken advantage of the exemption available in accordance with section 33 of FRS 102 'Related party disclosures' not to disclose transactions entered into between two or more members of the group, as the company is a wholly owned subsidiary undertaking of the group to which it is party to the transactions.

4
Parent company

The ultimate parent undertaking is C D Medical Limited, a company registered in England & Wales.

2023-01-312022-02-01true11 October 2023CCH SoftwareCCH Accounts Production 2023.300No description of principal activityMrs E M Armstrong GrimshawMr  B MillerMr B L Millerfalse048933022022-02-012023-01-31048933022023-01-31048933022022-01-3104893302core:ShareCapital2023-01-3104893302core:ShareCapital2022-01-3104893302bus:Director22022-02-012023-01-3104893302core:CurrentFinancialInstruments2022-01-3104893302bus:EntityNoLongerTradingButTradedInPast2022-02-012023-01-3104893302bus:PrivateLimitedCompanyLtd2022-02-012023-01-3104893302bus:SmallCompaniesRegimeForAccounts2022-02-012023-01-3104893302bus:FRS1022022-02-012023-01-3104893302bus:AuditExemptWithAccountantsReport2022-02-012023-01-3104893302bus:Director12022-02-012023-01-3104893302bus:CompanySecretary12022-02-012023-01-3104893302bus:FullAccounts2022-02-012023-01-31xbrli:purexbrli:sharesiso4217:GBP